Conceptual omics image represented by many small squares in various shades of purple on a black background.
Article

Making the Most of Multiomics Data with a Single Platform

Researchers use nanopore sequencing to produce ultra-rich multiomics data for next-level human disease research.

Share

Human disease research depends on a range of multiomics approaches that researchers use to understand underlying mechanisms and advance biomarker and drug discovery. However, the need for multiple platforms to gather data leads to resource-heavy, laborious, and time-consuming workflows that may nevertheless exclude important information.

Download this brochure from Oxford Nanopore Technologies to learn how researchers use nanopore sequencing to gather ultra-rich multiomics data, maximize the information obtained from valuable tissue research samples, and resolve the molecular mechanisms of disease.

Top Image Credit:

iStock

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies